Financing the new French industry and meeting the challenge of transitions “Our ambition is to help French companies grow through long-term investment” ISALT is a portfolio management company whose mission is to invest long-term in the capital of listed or unlisted French companies. Since its creation in 2020, ISALT has set itself the ambition of developing a long-term investment platform with the aim of providing stable and constructive capital to French companies operating in key sectors for our economy. As such, it implements an investment strategy which consists of taking significant, long-term stakes in the capital of French companies and …

Type: Incubators & VCs

Every Embryo, Every Procedure, Every Cycle Counts Nexpring Health unites industry leaders in reproductive technology, combining over 40 years of expertise from Cook Reproductive Health, Hamilton Thorne Inc., Irvine Scientific, Planer, IVFTech, Gynemed, Gynétics, Microptic, Tek-Event and Embryotech portfolio. We deliver advanced solutions that simplify complex challenges in fertility care, providing unwavering support at every critical moment. Our hands-on partnership goes beyond technology to help clinics deliver consistent, high-quality outcomes for patients worldwide. Assisted Reproductive Technologies, Transgenic Technology, Reproductive Toxicology, Developmental Biology, Animal Breeding/Production, Stem Cell Research, Reproductive Biology, IVF, and In Vitro Fertilization

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

The most trusted biopharma licensing database. DealForma helps biopharma business development analysts be better at industry research by providing curated data and direct analyst support. All database subscriptions include time to have us complete your data projects with experienced industry analysts. Prepare for partnering meetings, benchmark deals and funding trends, and track the technologies, products, and therapeutic areas you care about. All in an easy-to-use interface. Learn more at dealforma.com Biotech and pharma partnerships, M&A, Venture funding, Deal trends, Clinical trials, Product sales, Business developers, Company profiles, and Licensing

Type: Startup Activities: it services Technologies: Data Analytics

Portfolio of transcatheter & endovascular anchoring solutions Endoron Medical portfolio of anchoring solutions expands and enhances treatment for patients by making current devices better across the aortic continuum from TAVR to EVAR. Aortodock was developed as a transcatheter valve docking solution for calcium- and leaflet-independent anchoring and stability, enhancing procedural predictability and reliability, expanding treatment options for vascular heart disease Aortoseal was developed to mimic the reliable hand-sewn suturing technique from open surgery, evenly distributing staples around the circumference of the aorta, creating leak and migration free anastomosis. Endoron is a proud beneficiary of the EIC grant. The European Innovation …

Type: Startup Activities: deeptech

AI that handles patient communication perfectly, so healthcare teams can prioritize care. Hello Patient is transforming healthcare communication through advanced conversational AI. After spending 3.5 years scaling Carbon Health's technology during its hypergrowth, our founding team witnessed firsthand how much clinical time gets wasted on basic communication—great clinicians buried in administrative work, patients frustrated by missed connections and phone tag. Our enterprise-grade AI platform proactively engages patients through perfectly timed calls and texts, naturally resolving complex interactions end-to-end—from patient acquisition and scheduling to retention. Built with security and compliance at its core, our technology integrates seamlessly with existing healthcare infrastructure …

Type: Startup Activities: healthtech Technologies: A.I.

Industry-leading generative AI agents for healthcare call centers. Our mission is to make exceptional healthcare accessible anytime, anywhere, for anyone.At Assort Health, we believe healthcare should feel effortless and connected — quick answers, clear communication, and seamless access to care. That’s why we’re building a new foundation for how patients and providers connect, driven by AI, built to embrace the complexities of healthcare, and tailored to each provider’s unique needs. Assort is the most comprehensive patient experience platform powered by specialty-specific agentic AI. Assort’s omnichannel AI agents seamlessly integrate with EHR/PMS and complicated provider preferences to eliminate lengthy hold times …

Type: Startup Activities: healthtech Technologies: A.I.

Transforming Energy into Therapy Galvanize Therapeutics is developing therapies to deliver life-changing healthcare solutions to patients and their doctors at the convergence of biology, engineering, and care delivery. medical device, COPD, AF, Oncology, Intervential Oncology, Intervential Pulmonology, AFib, PEF, PEF Ablation, Soft Tissue Ablation, Cardiac Arrhythmias, and Chronic Bronchitis

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Scalable, Plant-based, High Performance Material Innovation Evoco is a material innovation company harnessing the power of nature through plant-based chemistry to develop the next generation of high-performing, sustainable products.​ innovation, R&D, plant based materials, manufacturing, global supply chain, footwear, product development, design, Advanced Materials, ESG, LCAs, R&I, and plant based chemistry

38 similar entities Type: Startup Activities: deeptech Technologies: New Materials

Championing the Industrial Bioeconomy The BBIA exists to champion the industrial bioeconomy to accelerate the development and adoption of bio-based and biodegradable materials and products through advocacy, collaboration, and education. We do this to reduce the impact of human consumption on the planet. Our vision is for a more sustainable future, where the UK is a global leader in developing, manufacturing, using and exporting bio-based and biodegradable solutions. biowaste, sustainable packaging, compostable packaging, bioplastics, biobased materials, bioeconomy, and biochemicals

Type: Startup Activities: greentech manufacturing cleantech Technologies: New Materials

Moving Pharma Forward Protagoras is a fast-growing, digitally-minded management consulting firm focused on strategy, implementation, and change management in the pharmaceutical and life sciences industry. Founded in 2019, our London-based team offers extensive experience supporting a wide range of clients including top 50 global biopharma companies, cutting-edge biotech, and life science investors / private equity firms. Our mission is to do impactful work and with every project we do, we seek to bring real value to our clients’ organisations. We work the way our clients need us to, building truly customised solutions to meet our clients’ needs. Life Sciences Consulting …

Type: SMB Activities: healthtech

Macrophage Biology Revealed:Developing breakthrough approaches to macrophage activity to change the course of disease Macomics is a macrophage drug discovery company, passionate about the therapeutic potential of targeting macrophages for better therapies. We are developing novel treatments for diseases where current therapeutics are severely limited or ineffective. Our validated and proprietary platform, ENIGMACTM enables the translation of human disease-specific macrophage biology into genetically validated and actionable therapeutic targets. Our Macrophage Atlas is one of the largest pan-disease and healthy tissue macrophage RNAseq collections globally. Using this vast resource and our bioinformatics expertise, we explore fundamental questions about conserved pathways in …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

AI Platform for Life Sciences that Scales Betteromics is a GenAI-powered, secure, collaborative, cloud-based DevOps-as-a-Service (DaaS) platform that accelerates innovation for life science companies. By seamlessly integrating cutting-edge science, streamlined processes, untamed data, and the power of generative AI, Betteromics empowers organizations to extract valuable insights from massive amounts of multimodal data across the entire drug lifecycle. Real-time insights and advanced signal detection, driven by GenAI, facilitate data-driven decision-making, enabling scientists and researchers to develop personalized medicine faster and more efficiently.

Type: Startup Activities: it services deeptech biotech Technologies: A.I.

Treating chronic disease by targeting inflammation at its source NodThera is developing a new class of potent and highly selective NLRP3 inflammasome inhibitors for the treatment of diseases driven by chronic inflammation. We’re building a dynamic team of people across our offices in Cambridge, UK and Boston, MA; all united by our shared ambition, enthusiasm, and creativity.

Type: Startup Activities: deeptech biotech

Investing in Innovation: Commercialising World-Class Research from UCL The UCL Technology Fund is dedicated to investing in intellectual property commercialisation opportunities arising from UCL’s world-class research base, focusing in particular on the physical and life sciences. The Fund supports UCL in achieving the full potential of innovations that have prospects for outstanding societal and market impact, right through the development journey from initial proof of concept to practical commercial application. #IntellectualProperty, #Innovations, and #TechTransfer

Type: Incubators & VCs

Developing a new generation of therapies to protect, restore, and improve vision EyeBio is a privately held ophthalmology biotechnology company dedicated to developing and delivering a new generation of therapies to protect, restore, and improve vision in patients with sight-threatening eye diseases. ophthalmology, biopharmaceuticals, and biotechnology

Type: Startup Activities: biotech deeptech

A clinical stage biotechnology company developing ground-breaking therapies for cardio-renal disease. At Corvidia Therapeutics, we are creating precision therapies by using the science of genomics in new ways. Through random genetic mutation, nature conducts experiments, subtly changing how key proteins work in our bodies and influencing the factors that drive diseases differently in different groups of patients. We study the networks of these genetic variations and how they affect specific diseases in specific patients, allowing us to understand how a personalized drug in complex diseases may behave before we ever begin a clinical trial. We believe that by leveraging the …

Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

The Swoop® system brings MR brain imaging within reach. Nasdaq: $HYPR The Swoop® system brings MR brain imaging within reach. Our mission is to revolutionize patient care globally through transformational, accessible, clinically relevant diagnostic imaging and data solutions. Hyperfine, Inc. (Nasdaq: HYPR) is the groundbreaking medical technology company that has redefined brain imaging with the Swoop® system—the world’s first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system capable of providing imaging at multiple points of care. The Swoop® system received initial U.S. Food and Drug Administration (FDA) clearance in 2020. It is a portable ultra-low field magnetic resonance imaging device …

Type: Startup Activities: healthtech deeptech Technologies: A.I.

Mediar Therapeutics is a clinical stage company advancing first-in-class therapies to halt fibrosis progression. Mediar Therapeutics is pioneering a new approach to fibrosis treatment that aims to halt the disease at a different source – the myofibroblast, the key pathogenic cell in fibrosis that drives scarring, disease progression, and ultimately organ failure. Mediar was founded based on a deep understanding of the complex science underlying fibrosis progression. By combining novel targets with reliable, easily detectable blood biomarkers and familiar modalities, Mediar’s goal is to bring forward novel anti-fibrotic therapies that potentially have a precision medicine approach. For more information, contact …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

First-in-class therapeutics for autoimmune disorders We develop first-in-class biologics for several underserved autoimmune conditions. Our therapeutic approach aims to preserve and re-establish organ cell function, transforming the treatment paradigm for intractable autoimmune diseases

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Harnessing the Power of Epigenetic Editing Chroma Medicine is pioneering a new class of single-dose genomic medicines that harness epigenetics, nature’s innate mechanism for gene regulation, revolutionizing the treatment of disease. Epigenetics is nature’s central mechanism for gene regulation, governing cell phenotype and function by precisely controlling gene activity without changing the underlying DNA sequence. Building on groundbreaking research from the world’s foremost genomic medicine experts, Chroma Medicine is working at the cutting edge of precision genomics, building an entirely new class of therapeutics to achieve unparalleled control of gene expression. *Note: Be aware of fraudulent recruiting advertisements and scams: …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Carbon Negative Cement & Concrete Prometheus Materials is a provider of reduced carbon cement technology, serving the entire cement and concrete industry. With the support of microalgae, a carbon negative cement is made possible through our breakthrough cement replacement blend called ProZEROTM️. The most cost-effective way to reduce your carbon, ProZEROTM️ means you can keep the cement, but lose the carbon. We can help you reduce carbon or go carbon negative, depending on the goals of your project. Learn more at prometheusmaterials.com Bio-cement, Bio-concrete, Net-zero carbon, biotechnology, Building materials, Algae, sustainable construction, cement, and concrete

Type: Startup Activities: greentech deeptech cleantech Technologies: New Materials

Biotech company focusing on the discovery and development of novel targeted medicines to treat cancer and fibrosis Redx Pharma is a clinical-stage biotechnology company focused on the discovery and development of novel, small molecule, highly targeted therapeutics for the treatment of cancer and fibrotic diseases Our team of scientists are based at our labs at Alderley Park, Cheshire, the UK’s largest single site life science campus. The team is made up of world class medicinal chemistry, biology and clinical capability with deep-rooted biotech and large pharma experience. Redx's lead asset, the selective ROCK2 inhibitor, zelasudil (RXC007), is in development for …

Type: Startup

DEVELOPING THE NEXT GENERATION OF TREATMENTS FOR CARDIO-RENAL DISEASES. DEVELOPING THE NEXT GENERATION OF TREATMENTS FOR CARDIOVASCULAR DISEASES.

Type: Startup Activities: deeptech biotech

Recor Medical, headquartered in Palo Alto, Calif., a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., is a medical technology company focused on transforming the management of hypertension. Recor has pioneered the use of the Paradise Ultrasound Renal Denervation system for the treatment of hypertension. The Paradise system is FDA approved in the United States, bears the CE mark, and is an investigational device in Japan, hypertension, medical device, and Intervention cardiology

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Our expertise, Your discovery Cellomatics is an ISO-certified, specialised preclinical CRO with expertise in translational human cell-based models. We support drug discovery across multiple therapeutic areas by capturing disease biology in physiologically relevant systems, enabling more predictive and clinically meaningful insights. At Cellomatics Biosciences Ltd., we understand the complexities of immunology research and the importance of generating data you can trust. Our immunology assay services are designed to accelerate discovery and development through high-quality, customizable solutions that address the unique needs of every project. We combine: • Scientific expertise to ensure robust study design and execution • Fresh donor material …

65 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We want every patient to become a Cancer Survivor. Cure 51 is a TechBio aiming at creating the first ever worldwide database of Cancer Survivors. The company was co-created with leading oncology centres and has already identified more than 1500 survivors in 42 countries across all continents. The company has developed its own data collection and discovery platform as well as a dedicated Central Lab to proceed to a multiomic sequencing of the survivors’ samples. Through this approach, Cure51 will identify robust therapeutic targets, validated by its scientific community, in order to develop novel drugs to cure Cancer. The focus …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Europe’s largest and leading center for excellence in artificial intelligence and modern robotics. Cyber Valley is Europe’s largest center of excellence for artificial intelligence and modern robotics. By creating a vibrant ecosystem, facilitating smooth collaboration and rapid knowledge-exchange between science, business, and society, we envision a future where the full potential of intelligent systems is leveraged for the greater good of the world. Cyber Valley stands for entrepreneurial spirit and is made up of three key parts: the Innovation Campus, the Company (GmbH), and the Community. Together, we aim to boost research, development, application, and acceptance of intelligent systems– with …

Type: NGO, Think-tanks, Ed, & Culture Activities: it services

Global alternative asset manager with more than three decades of experience generating attractive returns ICG (LSE: ICG) is a global alternative asset manager with $127bn* in AUM and more than three decades of experience generating attractive returns. We operate from over 20 locations globally and invest our clients’ capital across Structured Capital; Private Equity Secondaries; Private Debt; Credit; and Real Assets. Our exceptional people originate differentiated opportunities, invest responsibly, and deliver long-term value. We partner with management teams, founders, and business owners in a creative and solutions-focused approach, supporting them with our expertise and flexible capital. *As at 31 December …

Type: Incubators & VCs

Apollo is a high-growth alternative asset manager. Apollo is a high-growth, global alternative asset manager. In our asset management business, we seek to provide our clients excess return at every point along the risk-reward spectrum from investment grade credit to private equity. For more than three decades, our investing expertise across our fully integrated platform has served the financial return needs of our clients and provided businesses with innovative capital solutions for growth. Through Athene, our retirement services business, we specialize in helping clients achieve financial security by providing a suite of retirement savings products and acting as a solutions …

Type: Incubators & VCs

We invest in an ageless future. We support early-stage biotech and longevity-focused founders that are changing the world. We help these companies gain industrial momentum, raise capital, and shape the future of biotech. Our approach is based on growing the whole ecosystem. We fund companies in complementary industrial sectors, empowering us to build a broad community of biotech innovators that can exchange their expertise and build on each other's successes.

Type: Incubators & VCs

Reporting from the frontiers of health and medicine. Reporting from the frontiers of health and medicine We take you inside the science labs and hospitals, biotech boardrooms and political backrooms. We dissect crucial discoveries. We examine controversies and puncture hype. We hold individuals and institutions accountable. We introduce you to the power brokers and personalities who are driving a revolution in human health. These are the stories that matter to us all. Get access to exclusive content: http://www.statnews.com. Follow us on Twitter @statnews and on Facebook at facebook.com/statnews news, science news, medicine, health, biotech, pharma, health tech, covid, hospitals, and …

Type: Media

Northzone is a venture capital fund shaped by lives as entrepreneurs and investors. Founded in 1996. Northzone is a technology investment partnership. With two decades of experience, we have been chosen by some of the best entrepreneurs as their long-term partner for growth. With offices across the Nordics, London and in New York, we work around the clock to connect our companies with customers, business partners and key talent on a truly international scale. As former entrepreneurs ourselves, we have been sat on both sides of the table, and place the relationships with our Founders at the core of our …

Type: Incubators & VCs Activities: e-commerce Technologies: SaaS

Life Sciences dedicated VC firm Panakès Partners is a Venture Capital firm, based in Milan, which invests in the most ambitious companies and teams, developing revolutionary technologies and products, in the field of life sciences, aiming to improve the lives of people around the world, in two funds. Panakès, founded in 2015 by Fabrizio Landi, Alessio Beverina and Diana Saraceni, has 250 million under management. Panakes brings strong entrepreneurial and financial expertise to portfolio companies well beyond just capital, relying on a wide network of clinicians and industry experts. We have established relationships with selected industrial partners to assist our …

Type: Incubators & VCs

Innovestor is an active Finnish investment manager on a mission to make Good Money. Innovestor is an active Finnish investment manager on a mission to make Good Money. Innovestor focuses on venture capital, real estate, and energy storage. We also offer corporate venturing services. By bringing together entrepreneurs, investors, and partners, we build a powerful community that will make a positive impact. Our mission is to make Good Money. We believe that the world needs bold visionaries who invest their time and money in shaping a better future. Join us on a mission to support and grow businesses that create …

Type: Incubators & VCs

Making companies a better place. One app at a time. Odoo is an open-source suite of integrated business applications actively programmed, supported, and organized by Odoo SA. Odoo is similar to many open-source projects where customized programming, support, and other services are provided by an active global community and partners network. The community is comprised of more than 1,500 active members and has contributed more than 4,500 modules to the ongoing enrichment of Odoo. The network of certified partners, established in more than 120 countries, deploys the solution locally. The software, with more than 1,500 downloads a day, is one …

Type: Large company Activities: it services

Data intelligence platform tracking 7M+ companies across 3K+ feeds and 50+ global markets. Founded in 2012 by former Venture Capitalists, Tracxn is a leading market intelligence platform for private company research. We track 7.5M+ companies across 3K+ curated feeds spanning 50+ geographies, covering industries, sectors, sub-sectors, networks, and affiliations globally. Powered by a unique combination of human analysts and technology, Tracxn scans billions of data points to deliver structured, actionable intelligence for private markets. Backed by investors such as Accel and Sequoia, Tracxn serves 1000+ customer accounts across 50+ geographies, including Venture Capital and Private Equity funds,Corporate M&A and Innovation …

Type: Large company Activities: fintech

Namsen Capital is a capital advisory boutique for emerging growth companies willing to access U.S. and EU investors Namsen Capital is a capital advisory boutique for emerging growth companies willing to access U.S. and EU investors. Over years, Namsen Capital has developed a sound expertise in leading successful fund raisings in Life sciences and Healthcare sector Life Sciences, Fund Raising, Nasdaq, Euronext, Series A, Series B, Series C, IPO, Healthcare, and Strategy

Type: Incubators & VCs

Science for brain health Brain&Mind is the French Neuroscience Biocluster, a top-notch research community dedicated to make neuroscience more predictive and more impactful. We are brains and minds, working together, to transform ideas into real-life solutions -- for brains and minds. Occupational Health, Therapeutics, Digital therapeutics, Medical technologies, Preventive approaches, Training&entrepreneurship, Start-up acceleration, and Biotherapies

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech Technologies: Synthetic Biology

Abzena is the leading end-to-end bioconjugate & complex biologics CDMO+CRO, focused on rapidly moving medicines forward. Abzena is the leading end-to-end bioconjugate, ADC, and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. With the ability to tailor its strategy and customer experience to each project, Abzena develops and implements innovative solutions that enable biotech and biopharma companies to realize the full potential of their molecule and move medicines forward faster. The company has research, …

72 similar entities Type: Startup Activities: manufacturing biotech deeptech Technologies: Synthetic Biology

Trans-septal Mitral Valve Replacement HighLife is a trans-catheter mitral valve replacement company committed to bringing the best minimally invasive technology to the patients.

Type: Startup Activities: deeptech

The Wellcome Sanger Institute is a world leader in genomics research. We generate and analyse data at a scale not easily possible elsewhere. We apply and explore genomic technologies to advance the understanding of biology and improve health. Our ambition is vast – we take on projects that are not possible anywhere else. We use the power of genome sequencing to understand and harness the information in DNA. Funded by Wellcome, we have the freedom and support to push the boundaries of genomics. Our findings are used to improve health and to understand life on Earth. genetic sequencing, bioinformatics, medical …

Type: Large company Activities: deeptech biotech

The authoritative voice on life science innovation: news, analysis, events, awards, webinars & whitepapers Xconomy is the authoritative voice on biotech’s exponential economy – the realm of business and innovation characterized by accelerating and forward-looking growth, and the catalyst of health and wellness advancements. For more than a decade, Xconomy has provided timely, insightful, close-to-the-scene information about the trends, companies, and personalities that best exemplify today’s life science innovation economy. Xconomy news and analysis uniquely covers the business of biotech, healthtech, and venture capital by focusing on the leaders who drive the future – from startup to IPO and beyond. …

Type: Media

Disruptive hearing technology start-up (CLOSED) Situational hearing loss is a huge and growing problem worldwide, affecting over 80% of people over 40. Often called ‘The Cocktail Party Problem’, this means that sufferers can hear speech clearly in quiet rooms, but in noisy situations they find it hard to follow conversations. AudioTelligence’s aisoTM technology can supercharge hearing enhancement on your device. AisoTM goes a step further than other solutions which simply reduce background noise, by isolating and extracting the speech or sound that the user wants to hear from surrounding noise and unwanted sounds. With aisoTM, users can effectively regain their …

Type: Startup Activities: it services Technologies: Embedded Systems

Investing in life changing science Arix Bioscience plc is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting edge advances in life sciences. We collaborate with exceptional entrepreneurs and provide the capital, expertise and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors.

Type: Incubators & VCs

Venture Capital Management Software Versible is a Venture capital management SaaS solution built for VC firms & Founders. VC firms can manage their entire operation on a single dashboard Founders can raise capital, track KPI's and generate investor reports SaaS, Venture capital, Funding, Deal flow, Investor relations, and CRM

Type: Incubators & VCs

A unique gastronomic and event experience & committed, driven by our resident Chef Thierry Marx For nearly 20 years, Té has designed and organized your tailor-made receptions in collaboration with passionate chefs and artisans. Under the leadership of our Michelin-starred resident Chef Thierry Marx, our services embody an inventive and subtle vision of gastronomy, reconciling know-how, sense and modernity. Our teams strive to make each event a unique culinary and emotional experience, just like you. A responsible events professional, Té stands out for its strong social and environmental commitments. Our menu is made up of more than 70% responsible products …

Type: SMB Activities: traveltech Technologies: Decarbonization

Pioneer of vertical dance A pioneer in the practice of vertical dance, the Retouramont company is recognized by the profession as the reference in its field. The company does not stop at one discipline, it mixes different arts in a given territory to construct a singular work. The city offers an incredible variety of playgrounds and movement creation areas. She takes over her spaces and buildings in a new way each time. From historical monuments (Saint-Eustache church, Mont-St-Michel abbey, Château de Vincennes, etc.) to the most modern buildings (Singapore skyscrapers, BnF-François Mitterrand, residential towers, etc.), the company knows how to …

Type: SMB Activities: constructiontech

Link builder for 30 years Carrément is a marketing and advertising company based in Paris, France. Event communication has been our core business for 30 years. Event & Digital. We create links between your internal or external audiences, networks, prescribers, customers, salespeople, etc. We act “multi-channel”: from creative design to field operations and mastery of technological tools. We are connected between your beliefs and our creative ideas. ------------------------------------------------------------------------------ Event We design BtoB events from strategic thinking and creation to operational implementation on the ground. Our 3 strong points? 1 – Promote relationships between all your audiences, networks, prescribers, customers, sales …

Type: SMB Activities: martech Technologies: SaaS

Founded in 2014 by Eric Bendahan, ELEVA Capital is an independent investment manager. Building on its long-standing expertise in European equities, ELEVA Capital has gradually developed other areas of expertise in small & mid caps, impact investing, fixed income, multi-asset and structured products through its subsidiary ELEVA Solutions. The firm is proud of its independence and looks to differentiate through its performance, client proximity and integrity. In addition, ELEVA Capital has a long-term, innovative and industry-leading partnership with UNICEF, allocating c.10% of the firms profits via the ELEVA Foundation. ELEVA Capital is authorized and regulated by the Autorité des Marchés …

Type: Incubators & VCs

Accelerating the future of minimally invasive care. Intuitive Ventures is the venture capital arm of Intuitive (Nasdaq: ISRG), headquartered in Sunnyvale, Calif. Through its inaugural $100 million fund, Intuitive Ventures invests in and is advancing the digital, device, therapeutic and diagnostic ecosystems of minimally invasive care and beyond, fostering a disciplined and sustainable investment platform that will offer strategic and financial returns for the long term. Building on Intuitive's entrepreneurial beginnings as a medtech and healthcare success story in Silicon Valley, and as a digitally native company, Intuitive Ventures is well-positioned to identify and support early-stage innovators meeting that challenge. …

Type: Incubators & VCs

The Protein Design Company (TM) - new proteins and biochemistry for the production of valuable sustainable molecules Arzeda, The Protein Design CompanyTM, is a synthetic biology company that creates novel proteins, enzymes and specialty chemical products that compete on performance, cost and sustainability. Partnering with Fortune 500 companies, Arzeda has developed a portfolio of enzymes and specialty chemicals for polymers, pharmaceuticals, industrial chemicals and other advanced applications. More information at www.arzeda.com. Synthetic Biology, Bio-based Chemicals, and Protein Design

92 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

We set the national direction on space. Part of the Department for Science, Innovation and Technology. We boost UK prosperity, understand the Universe, and protect our planet and outer space. The UK Space Agency plays a major role in delivering the government’s National Space Strategy. We nurture a thriving space ecosystem – a network of investors, scientists, engineers, integrators, academia, and research labs – and a sector that generates an annual income of £17.5 billion and employs nearly 50,000 people across the country. Our staff include scientists, engineers, commercial experts, project managers and policy officials who: - catalyse investment to …

Type: Public Activities: spacetech

We support visionary entrepreneurs to reinvent industries through technology. At United Ventures we look for daring entrepreneurs willing to develop innovative products and technologies, who acknowledge the challenges and risks of our times and still crave to come out on top in business. As entrepreneurs ourselves, our mission is to spot winners and drive them to achieve success and worldwide recognition through our mentorship, financial and business development support. With a long-standing track record of both start-up and scale-up technological companies, we can boast the industry expertise, mentorship and business networking that it takes to create a success story. Thanks …

Type: Incubators & VCs

Accelerating the pace of innovation. Triple Ring accelerates the pace of innovation, so you can drive growth, start new businesses, launch breakthrough products, overcome hard problems, improve health, and change lives. We are a healthcare-focused co-development company headquartered in Silicon Valley, with offices in Boston, Toronto, and Copenhagen. Our services span 3 key business lines: Corporate venture building, Technology and product-development services, and Technology translation for government programs. Founded in 2005, Triple Ring has an unparalleled track record supporting clients from startups to many of the world’s largest MedTech and Life Sciences companies. Advanced Research & Development - applied to …

Type: Incubators & VCs NGO, Think-tanks, Ed, & Culture Activities: deeptech healthtech biotech

The home of the UK tech ecosystem. About the tech industry, for the tech industry, UKTN is the ultimate resource for the latest UK tech news, views, information, data and events. Formerly Tech City News, UKTN is the new name and destination for UK tech. Not only do we provide you with the latest news on the UK tech space – from recent investments to changes in policy – our close relationships with industry leaders and game changers gives us the edge in publishing exclusive interviews with inspiring tech pioneers and producing events that bring the industry together and celebrate …

Type: Media

Tech.eu is the premier online publication dedicated to the growing European technology ecosystem(s). Tech.eu is the premier online publication dedicated to the growing European technology ecosystem(s). We deliver a range of editorial products with a clear focus on curated news, actionable information and educational interviews with movers and shakers from across Europe, combined with insightful market intelligence reports based on our proprietary database, events, a jobs platform and a variety of other services.

Type: Media

Kymab, a Sanofi company, based in Cambridge UK, is working to provide novel solutions in drug and vaccine development. Kymab, a Sanofi company, is a clinical-stage global biopharmaceutical company focused on the discovery and development of fully human monoclonal antibody drugs using its proprietary antibody platform which contains a full diversity of human antibodies, making it the most comprehensive antibody development platform available. Kymab’s platform has been designed to maximise the diversity of human antibodies produced in response to immunisation with antigens. Selecting from a broad diversity of fully human antibodies assures the highest probability of finding drug candidates with …

25 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Transforming cancer immunotherapy with next generation ADCs Mablink Bioscience is a French biotechnology company that is actively involved in the fight against cancer by bringing disruptive therapeutic solutions. With its Antibody-Drug Conjugates (ADC) masking technology, Mablink Bioscience aims to dramatically improve the efficiency of ADC therapies and accelerate the development of new treatments. Based in Lyon, where it is developing an unprecedented innovation center, Mablink currently has around 30 employees with diverse backgrounds. biotechnology, drug development, drug discovery, oncology, and R&D

64 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Where innovation meets talent We are now ready to take the next step to create a launchpad with significant impact on the creation of new startups in Italy. Platform with data from startups, innovative companies, investors and skilled people. Educational platform to support mindset building and training for a future generation of entrepreneurs with clear vertical specializations. Services and support for a new generation of startups with appropriate growth models Flexible space to bring together the ecosystem and support flexible expansions for startups and Corporates/SMEs. "The largest Italian community targeting founders, investors, developers and students "​ Source: IBM & Talent …

Tags: H2020 Type: Incubators & VCs

Taking action against cancer OncoSTART is a multi-partner program aimed specifically at encouraging & boost the creation of oncology businesses through a continuum of actions dedicated to training and support bringing together a maximum of stakeholders working in the field of the fight against cancer to attest to the dynamics of the sector recognized nationally and internationally. Program divided into 3 types of actions covering the entire innovation value chain: o Awareness raising: raise awareness, throughout the national territory, of aspiring entrepreneurs (doctoral students, young researchers, researchers) in the field of oncology; o Training: offer a training offer to motivated …

Type: NGO, Think-tanks, Ed, & Culture Activities: edtech

Financing strategy experts Support Start-ups, VSEs and SMEs at each stage in their development. Start 2 Scale is an expert in financing strategy for innovative and fast-growing companies. We structure and then seek non-dilutive financing (bank & public) for our clients. Building on our status as a Company with a Mission, we aim to support companies engaged in the social and environmental transition, and to promote impact at all levels (supported companies, selected financing, mentoring, etc.). Innovation, Growth, Financing advice, Financing search, Financial strategy, Non-dilutive, Complex financing, Bank financing, and Public financing

Type: Incubators & VCs

“Area of Major Interest” project for the Ile-de-France Region, led by Paris Cité University BioConvergence for Health (BioConvS) is an “Area of Major Interest” (DIM) initiative of the Ile-de-France Region which aims to structure the synthetic biology, biotherapy and bioproduction communities, to support the transition from scientific excellence to innovation, and position the Île-de-France region as an international reference in the field. BioConvS is led by Université Paris Cité in partnership with Sorbonne Université, Institut Curie - PSL, Institut Micalis (INRAe, AgroParisTech, Université de Saclay), INSERM, Généthon, Génopole and others. BioConvS brings together actors from the public and private sectors …

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech

The grouping of players who support and develop the health ecosystem in France! The grouping of players who support and develop the health ecosystem in France!

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech

A new player committed to tackle #glioblastoma and #brain #cancer Hemerion is a clinical stage HealthTech company. Its first breakthrough technology jointly designed with University of Lille, Inserm and University Hospital of Lille, addresses brain cancer and aims to help patients in their fight against glioblastoma. Hemerion results of over 10 years of leading academic and clinical researches on innovative approaches to treat Glioblastoma. Today, Hemerion owns a unique and disruptive technology, already evaluated in frontline approach to treat patients harboring brain cancer.

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech biotech

Investing for a Better World We are a venture capital firm that invests in the best impact startups. Inversión, Inversión de Impacto, Inversión en startups, Inversión en salud, Inversión en medio ambiente, Inversión en educación, Impact Investment, Health, HealthCare, Climate Change, Sustainability, Education, Venture Capital, Private Equity, and Fondo de inversión

Type: Incubators & VCs

Reshaping RecoveryTM Established in 2015 and based in France, SafeHeal is a clinical stage medical device manufacturer. Specializing in the development of anastomosis protection devices for colorectal surgery, SafeHeal’s premier device, Colovac, was invented to eliminate the need for diverting ostomies in patients undergoing colectomy. medical device

13 similar entities Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

More expertise, connections, and momentum. From Seed to Growth in Europe & beyond. Unlock: The Power of More. It takes more than capital to build real-world, cutting-edge technologies and companies that last. That’s why we commit the full power of our sector-focused investment teams and global network of customers, talent, top-tier follow-on investors, industry leaders, and experienced entrepreneurs to help you scale smarter and faster. With offices in London, Berlin, Paris, Vienna, and Abu Dhabi, we are on the ground across EMEA, helping our portfolio companies own their local markets and expand globally. From pre-seed to exit, we partner with …

Type: Incubators & VCs

The most valuable network for entrepreneurship & business 🌍 We're the global network for entrepreneurship, business and innovation. We're the place where startups, investors, corporations, innovation hubs, and public institutions can connect and improve their global competitiveness through innovation. Since 2012, South Summit, together with IE University, saw opportunities for entrepreneurs at a time when the crisis had hit hard. We believed that entrepreneurs would be the driving force behind a revitalized economy. Born as Spain Startup, we lead in the identification, organization and promotion of all kinds of initiatives with the aim of boosting entrepreneurship, generating business opportunities and …

Type: Event Activities: entrepreneurship consulting

The Financial Events Specialist FinEvents is an international financial event specialist, headquartered in Paris. Our Clients FinEvents works with corporates and financial institutions of all types that need to organise high quality financial events. Our Services We help clients organise key financial communication events: Initial Public Offerings Events, Merger & Acquisitions Announcements, Results Presentations, Investor Days and Annual General Meetings. Our Approach We offer a bespoke service tailored to your needs and cover every angle. When the stakes are high, time is short and faultless execution is imperative, FinEvents is the partner you can trust. Financial Events, AGM, Investor Day, …

Type: Event

Put addiction prevention at the heart of your health and safety & mental health at work. A company with a mission, GAE Conseil has established itself since 2014 as the reference firm in the prevention of addictive behavior at work. Our mission: to help you go beyond "everyone knows it but everyone is silent" in your organization when we talk about addiction, with the most comprehensive service offering on the market in terms of primary, secondary and tertiary prevention (consulting, awareness workshops, remote awareness, addiction training and Employee Assistance Program). Our teams support you on all of your projects in …

Type: SMB Activities: consulting Technologies: Cybersecurity

Growth Accelerator. ODYSSEE Venture, a French Venture Capital and Private Equity player established in 1999, is one of the first independent private equity asset management companies accredited by AMF. We specialized in growth companies and have raised over 600M€. FCPI, FIP, FCPR, Private Equity, Capital Développement, LBO, Small Cap, Mid Cap, and Capital Investissement

Type: Incubators & VCs

VERTEXA is an immersive therapeutic game, in virtual reality. Let’s digitalize health! VERTEXA digital therapy (Virtual Reality Therapy Exposition in Anorexia) aims to use virtual reality as a support tool in the form of a gamified and immersive psychoeducational course for patients suffering from eating disorders (anorexia, bulimia). The use of digital tools and new technologies now allow an innovative, personalized, motivating and accessible approach regardless of where our patients are cared for. The VERTEXA tool is intended to be autonomous: the patient is involved in his or her care. He will be immersed in a soothing universe, accompanied by …

Type: Public Activities: healthtech deeptech Technologies: VR

Expert in non-dilutive financing Advice and expertise in raising non-dilutive funds (public and private financing): Innovation, Investment, International. Established in Paris, Lyon, Bordeaux, Rouen, Toulouse and Lille. Every year, more than 1,000 new companies place their trust in us, with just as many customers calling on us again. We work over the long term with each company, because the overall financing strategy must be built over time. innovation assistance, International assistance, Search for public financing, Tax optimization, Bank financing, International, Impact financing, and Calls for projects

Type: Incubators & VCs

Together, invest for a better future A specialist in business development, UI has been committed and invested, for over 50 years, alongside leaders of growing startups, SMEs and mid-caps to create and develop economically and sustainably successful businesses. UI Investissement manages around 1.5 billion euros in assets and invests with 300 managers in sectors of activity essential to society such as health, agribusiness or industry and services. Development and transmission capital, the historic heart of UI's activity, represents more than half of the assets under management and allows more than 70 companies to benefit from the operational expertise and methodological …

Type: Incubators & VCs

IRDI Capital Investissement is a trusted partner, investor of the innovation and the SME on the South West of France. Based in Toulouse, Montpellier and Bordeaux, the management company IRDI Capital Investissement support in capital the companies based in the South West at every stages of their development (initiation, risk capital, development capital / transmission) for an cumulative oustanding amount of 300 million of euros.

Type: Incubators & VCs

Bringing the benefits of academic discovery to the world. Johns Hopkins Technology Ventures advances innovation ecosystems and develops tomorrow's solutions for today's biggest challenges. Our mission is to maximize the impact of Johns Hopkins University’s research excellence by facilitating the translation and commercialization of discoveries into accessible technologies, products, and services that benefit society. Diagnostics, Therapeutics, Medical Devices, Research Tools, Imaging, Healthcare IT, Engineering, Robotics, Digital Innovation, Digital Health, Precision Medicine, Materials Science, Oncology, Ophthalmology, Drug Discovery, Neurology, Commercialization, and Technology Transfer

Type: Incubators & VCs

Investing in and supporting the B2B founder journey from Zero to One Forum Ventures is the leading early-stage fund, program and community for B2B SaaS startups. Founded in 2014 as Acceleprise, we’re on a mission to make the B2B SaaS journey easier, more accessible and successful for early-stage founders, through funding, high touch programming, corporate perks and introductions, and an active SaaS community. Forum For Founders, our pre-seed program, provides founders with $100k in funding and 15 intense weeks of talks, events, mentorship and 1:1 guidance focused on go to market and fundraising. Forum Seed, our seed fund, backs exceptional …

Type: Incubators & VCs

Driving innovation and delivering solutions. NETL is a U.S. Department of Energy (DOE) national laboratory dedicated to advancing the nation's energy future by creating innovative solutions that strengthen the security, affordability and reliability of energy systems and natural resources. With laboratories and computational capabilities at research facilities in Albany, Oregon; Morgantown, West Virginia; and Pittsburgh, Pennsylvania, NETL addresses energy challenges through implementing DOE programs across the nation and advancing energy technologies related to fossil fuels. By fostering collaborations and conducting world-class research, NETL strives to strengthen national energy security through the development of innovative energy technologies. coal, clean coal, natural …

Type: Public Activities: energytech cleantech greentech Technologies: Decarbonization

Connecting Startups to Leading Experts in Venture Capital MeetFounders builds connections between startups and venture investors. We organize in-person and virtual conferences around the world with top experts in the startup and venture investment world, bringing these thought leaders together in action-packed events! Networking, investment opportunities, pitches from startups, and killer talks from VC and Angel Investors are just a few of the benefits from our events. Hope to see you there! venture capital, angel investment, startups, and conferences

Type: Event

Investors in transformative healthcare and biotechnology companies. Trusted advisors to entrepreneurs and operators. Exceptional entrepreneurs. Remarkable bonds. Extraordinary companies. Since 1996, Polaris has been guided by the fundamental beliefs that people come first and true partnerships make all the difference. Rooted in mutual respect and a shared passion for innovation, our relationships with outstanding visionaries principally in technology and healthcare have helped to change the world for the better.

Type: Incubators & VCs

We help fearless founders tackle hard problems with capital, resources and collaboration. HCVC is a venture capital firm that helps fearless founders tackle hard problems with capital, resources and collaboration. deeptech, venture capital, Seed, hardtech, pre-seed, and series A

Type: Incubators & VCs

The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent, diagnose, and treat it. MSK is dedicated to training the next generation of scientists and clinicians, who go on to pursue our mission at MSK and around …

Type: Incubators & VCs Activities: healthtech

Cathay Capital, Investing for global, sustainable transformation About Cathay Capital Group Cathay Capital Group is a global investment firm supporting companies at all stages throughout North America, Asia, Europe and Africa. By helping navigate the opportunities of globalization and sustainable transformation, Cathay is the partner of choice for companies aspiring to lead markets and make a positive impact. Its global platform connects people – from investors and entrepreneurs to management teams and leading corporations – across continents to share knowledge, the tools to scale, and achieve the extraordinary. Founded in 2007 with a strong entrepreneurial heritage, Cathay Capital now manages …

Type: Incubators & VCs

Silicon Valley Bank (SVB), a division of First Citizens Bank, is the bank of the world’s most innovative companies and investors. SVB provides commercial and private banking to individuals and companies in the technology, life science and healthcare, private equity, venture capital and premium wine industries. SVB operates in centers of innovation throughout the United States, serving the unique needs of its dynamic clients with deep sector expertise, insights and connections. SVB's parent company, First Citizens Bancshares, Inc. (NASDAQ: FCNCA) is a top 20 U.S. financial institution with more than $200 billion in assets. First Citizens Bank, Member FDIC. Learn …

Type: Incubators & VCs

We are leading the revolution in #sustainable #greenchemistry by offering a modular microwave based technology that can #unzip waste plastics back to their root chemical form. Styrene, Polyolefin wax, Lubricants, Microwave, Plastics, #CircularEconomy, #LowCarbonCement , CleanTechnology, #Nanorecycling, GreenSolutions, and #WasteReduction

64 similar entities Type: Startup Activities: cleantech greentech Technologies: Decarbonization

Industry leading publications, strategic consulting and a content-driven stakeholder engagement agency pharmaphorum.com, and its associated digital magazine Deep Dive, is a leading online destination for healthcare and pharmaceutical industry news, insight and debate. www.pharmaphorum.com pharmaceuticals, media, biotech, networking, marketing, sales, R&D, devices, diagnostics, commercial, content, communications, creative, consulting, publishing, market access, patients, digital health, and oncology

Type: Media

Founded by entrepreneurs for entrepreneurs, we invest financial and human capital in tech and impact startups. Founded by entrepreneurs for entrepreneurs, we invest financial and human capital in tech and impact startups. Venture Capital, Private Equity, Co-Investment, Tech, IA, Impact, Europe, Early Stage, and Growth

Type: Incubators & VCs

Major player in deeptech investment in the region GO CAPITAL is an independent management company managing seed capital and venture capital investment funds for more than €350 million and involved in innovative technological companies based in France. GO CAPITAL has already financed more than 100 innovative companies since its creation. Financing innovative companies, Fundraising, Seed funds, FPCI, and Innovation financing

Type: Incubators & VCs

This is where exceptional entrepreneurs get stronger Started in 2008 by and for founders, Newfund Capital is an early-stage VC firm active in France and in the USA. It has developed a strong culture centered around entrepreneurship and encourages initiatives to support the ambitions and the development of its portfolio companies. Newfund has $300 million in AUM subscribed mostly by entrepreneurs and family offices. Newfund's investment strategy is people-driven, focused on the constant search of entrepreneurs obsessed to realize their vision. We seek to understand entrepreneurs as individuals, appreciate their originality and play to their strengths. Greatness comes in all …

Type: Incubators & VCs Technologies: SaaS

Scaling responsible deeptech companies Jolt Capital SAS is a fully independent Private Equity firm authorized and regulated by AMF (Autorité des Marchés Financiers) that specialises in Technology, targeting investments into companies with revenues between €10m and €50m. Jolt Capital generates returns for its investors by enabling mid-sized technology-rich companies with strong fundamentals to execute their growth strategies, in sectors that offer good exit potential across software and hardware alike (cybersecurity, sensors, photonics, industrial processes, new energy systems, applied AI, robotics...) In providing growth capital to our portfolio companies, we support their scaling in new markets, new capacities and new acquisitions, …

Type: Incubators & VCs

An endowment fund to support and promote access to care for all patients as well as new medical and drug technologies. The HealthTech For Care endowment fund has three essential missions: - fostering the growth and development of the entire health ecosystem, - advocating for the advancement of innovative therapies and treatments to benefit patients, - promoting enhanced access to care for patients within the European healthcare ecosystem. Health

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech

We have a new page! Follow "Citeline, formerly Pharma Intelligence" to stay up to date on all our new posts moving forward as we transition! From drug and device discovery and development to regulatory approval, drug reimbursement to lifecycle management – you need to make smart decisions that give you an advantage in a fast changing market. The pharma and healthcare sector is facing unparalleled upheaval: increasing pressures on research and development teams to show a better return on investment, difficulty keeping abreast of complex regulatory and pricing and reimbursement environments and the race to get the best deal in …

31 similar entities Type: SMB Activities: biotech deeptech Technologies: Data Analytics

Early-Stage VC investor and Venture Studio backing bold entrepreneurs committed to planetary and human health. FoodLabs is a globally active Early Stage VC investor and venture studio, assisting the bold in building iconic companies committed to planetary and human health. Founded in 2016 by Christophe F. Maire, FoodLabs has built and invested in more than 80 early-stage companies, including the most seminal, fastest-growing European startups such as Infinite Roots, Formo, Meatable, and Klim. In the FoodLabs Studio, the team identifies new opportunities to tackle the biggest challenges of our time, along with the most daring entrepreneurs and scientists who have …

Type: Incubators & VCs

TechFundingNews.com (TFN) is all about interesting technology products from across the world which are getting funded to drive the change and define the future. TFN is a reliable and trusted source of news, features, and exclusive information on the tech startup world. It will also focus on providing all the tips and tricks, industry opinions, latest scoops and exclusive news making waves in the global tech ecosystem. For now, we are focussing on industries including fintech, AI, medtech, sustainability, IoT, mobility, consumer tech and more. But we have no category restrictions for an inspiring story that deserves coverage. technology, News, …

Type: Media

The seed fund of Ecole polytechnique, financed Alumni. Polytechnique Ventures is the seed fund of Ecole Polytechnique, created in 2020. Financed by the Alumni, the fund accompanies and invests in start-ups from the Ecole Polytechnique's innovation and entrepreneurship ecosystem. We target companies that will provide powerful solutions to the challenges of the transition to tomorrow's world. We support start-ups emanating from the Ecole Polytechnique ecosystem: founded by one or more Ecole Polytechnique alumni, incubated at Ecole Polytechnique or emanating from the school's laboratories. Our investment strategy is focused on early stage financing, in co-investment, with average initial tickets of €250K …

Type: Incubators & VCs

For reasoned progress, chosen shared Founded in 2000, the Academy of Technologies brings together 370 academics, including five Nobel Prize winners, all experts in their respective fields, and from very diverse backgrounds: the world of industrial and academic research, economists, sociologists, architects, doctors, etc. It analyzes the opportunities and risks linked to new technologies, and is committed to improving the attractiveness of technological professions, particularly among young people and women. The Academy issues proposals and recommendations to public authorities, socio-economic actors and citizens for better exploitation of technologies for the benefit of people, in accordance with its motto: reasoned, chosen …

Type: Public

We are a new generation of venture capital funders backing exceptional female founders and gender-balanced teams We are a new generation of venture capital funders backing exceptional female founders and gender-balanced teams. SISTAFUND is a pan-European VC fund backing female founders and gender-balanced teams, building companies that challenge the status quo. With €70 million, SISTAFUND will be deployed from pre-seed to Series A, mainly in France and Europe, with some investments in the U.S. SISTAFUND’s ambition is twofold: Drive the performance of backed companies, since start-ups founded or co-founded by women are 2.5 times more profitable investments than others (BCG …

Type: Incubators & VCs

Europe’s premier digital media platform for the global biotech industry. Labiotech.eu is Europe’s premier digital media platform for the global biotech industry. More than 130,000 monthly biopharma readers rely on Labiotech for insights into the latest innovations in biotechnology and our analysis of a dynamic industry. Subscribe today for access to our daily articles, in-depth content and extensive archive. Biotechnology, Life science, News, and Media

Type: Media

Le fonds français dédié aux start-up studios The French Tech Acceleration team within BPI France’s Innovation Division is dedicated to investing in start-up support structures such as accelerators and startup studios. Our current strategy is to primarily focus on supporting start-up studios initiatives, especially those operating in deeptech sectors (Greentech, Medtech, Biotech, Cybersecurity, Quantum systems etc...) which require significant capital needs. Deeptech startup studios aim to create high potential start-up developing disruptive technologies mainly resulting from the research work of public laboratories. In addition, we also support other growth sectors like construction sector, industry 4.0 or e-health. With 300M€ under …

Type: NGO, Think-tanks, Ed, & Culture Activities: it services

At Johnson & Johnson MedTech, we are working to solve the world’s most pressing healthcare challenges through innovations at the intersection of biology and technology. With deep expertise in surgery, orthopaedics, cardiovascular, and vision, we design healthcare solutions that are smarter, less invasive and more personalized. We are developing the next generation of med tech solutions to tackle the most pervasive and complex health challenges for people around the world.

Type: Large company